(MedPage Today) — The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated thrombotic microangiopathy (TA-TMA) in adults and kids ages 2 years and up, said maker Omeros on Wednesday…
It was an evening of effortless elegance and playful sophistication as family and friends gathered at the Manila House Private...
Childhood immunization rates for most vaccines have been falling since the pandemic, a CBC News analysis of provincial data has...
When to worry: The red flags of nerve pain you should never ignore Source: indianexpress.com
A self-drive car rental platform company believes the ongoing oil crisis in the country presents an opportunity to highlight the...
The Trump administration is updating rules for a key vaccine advisory committee in ways that may increase the voices of...
BTS take on "Hot Ones" — guess who lasted until the end. Source: www.philstar.com Medical Disclaimer: This content is shared...
